Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

UZPRUVO 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/UZPRUVO 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

UZPRUVO 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION

Stada Arzneimittel Ag🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 26, 2025
Approval ID: db93890bc6402d2f
Company: Stada Arzneimittel Ag
Type: Standard

Approval Details

Approval Id: db93890bc6402d2f
Drug Cima Aemps Name: UZPRUVO 130 MG CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1231784005
Holder Company Name: Stada Arzneimittel Ag
Marketing Company Name: Laboratorio Stada S.L.
Holder Company Detail Path: /organization/e8dccefce452d5e0/stada-arzneimittel-ag
Authorization Date: 2025-02-26
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 130 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Stada Arzneimittel Ag
Company Detail Path: /organization/e8dccefce452d5e0/stada-arzneimittel-ag

Company Information

Pharmaceutical Company Name: STADA Arzneimittel AG
Country Name: Germany
Website: http://www.stada.com

Active Ingredients

USTEKINUMAB

130 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 26, 2025

Approval ID

db93890bc6402d2f

Type

Standard

Back to CIMA-AEMPS Approvals